文献速递血栓与止血

血小板因子4与均一合成低分子量肝素的相互作用特征

Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins.
PubMed 文献 · J Thromb Haemost · 2019-10-20

本研究采用等温滴定量热法、圆二色谱、单分子力谱、酶联免疫吸附试验和血小板聚集试验,表征合成肝素类似物(6、8、10、12聚体及过硫酸化12聚体)与血小板因子4(PF4)及抗PF4/肝素抗体的相互作用。结果显示合成肝素样化合物与PF4的结合强于相应长度的动物源肝素;6聚体和过硫酸化12聚体与PF4复合后焓变较低、诱导PF4构象变化较小、相互作用力较弱;抗PF4/肝素抗体对PF4与≤8聚体肝素形成的复合物结合弱于与≥10聚体肝素形成的复合物。

要点

  • 合成肝素类似物与PF4的结合强于相应长度的动物源肝素。
  • 6聚体和过硫酸化12聚体与PF4复合时焓变低、构象变化小、作用力弱。
  • 抗PF4/肝素抗体对PF4与≤8聚体肝素复合物的结合弱于≥10聚体肝素复合物。

核心结论

  • 合成肝素类似物与PF4的结合特征强于相应长度的动物源肝素,且不同长度及硫酸化程度影响其与PF4的相互作用及潜在抗原性。

研究设计与样本

  • 采用等温滴定量热法、圆二色谱、单分子力谱、酶联免疫吸附试验和血小板聚集试验,表征合成肝素类似物(6、8、10、12聚体及过硫酸化12聚体)与PF4及抗PF4/肝素抗体的相互作用。

主要发现

  • 合成肝素样化合物与PF4的结合强于相应长度的动物源肝素。
  • 6聚体和过硫酸化12聚体与PF4复合后焓变较低、诱导PF4构象变化较小、相互作用力较弱,而8、10、12聚体则相反。
  • 抗PF4/肝素抗体对PF4与≤8聚体肝素复合物的结合弱于对PF4与≥10聚体肝素复合物的结合。
  • 在12聚体上增加一个硫酸基团形成过硫酸化12聚体后,其与PF4的结合特征发生显著变化。

临床怎么用

  • 本研究为表征新开发肝素类抗凝药物与PF4相互作用及潜在抗原性提供了模板,提示合成肝素类似物的长度和硫酸化程度可能影响肝素诱导的血小板减少症(HIT)相关抗体结合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heparins are usually produced from animal tissues. It is now possible to synthesize heparins. This provides the abilities to overcome shortages of heparin, to optimize biological effects, and to reduce adverse drug effects. Heparins interact with platelet factor 4 (PF4), which can induce an immune response causing thrombocytopenia. This side effect is called heparin-induced thrombocytopenia (HIT). We characterized the interaction of PF4 and HIT antibodies with oligosaccharides of 6-, 8-, 10-, and 12-mer size and a hypersulfated 12-mer (S12-mer). METHODS: We utilized multiple methodologies including isothermal calorimetry, circular dichroism spectroscopy, single molecule force spectroscopy (SMFS), enzyme immunosorbent assay (EIA), and platelet aggregation test to characterize the interaction of synthetic heparin analogs with PF4 and anti-PF4/heparin antibodies. RESULTS: The synthetic heparin-like compounds display stronger binding characteristics to PF4 than animal-derived heparins of corresponding lengths. Upon complexation with PF4, 6-mer and S12-mer heparins showed much lower enthalpy, induced less conformational changes in PF4, and interacted with weaker forces than 8-, 10-, and 12-mer heparins. Anti-PF4/heparin antibodies bind more weakly to complexes formed between PF4 and heparins ≤ 8-mer than with complexes formed between PF4 and heparins ≥ 10-mer. Addition of one sulfate group to the 12-mer resulted in a S12-mer, which showed substantial changes in its binding characteristics to PF4. CONCLUSIONS: We provide a template for characterizing interactions of newly developed heparin-based anticoagulant drugs with proteins, especially PF4 and the resulting potential antigenicity.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Nguyen TH, Xu Y, Brandt S, et al. Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins. J Thromb Haemost. 2019. PMID: 31573759. doi:10.1111/jth.14657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。